Posted in | News | Biosensors

Autoliv Chosen as Research Partner for Alcohol Sensor Development

Autoliv, a manufacturer and developer of automotive safety systems for automotive manufacturers, has announced that the company has been chosen to participate in the second phase of the Driver Alcohol Detection System for Safety (DADSS) program as a research partner.

The program is being co-sponsored by the Automotive Coalition for Traffic Safety (ACTS) and the US National Highway Traffic Safety Administration (NHTSA). ACTS is being funded by several vehicle manufacturers such as Chrysler, General Motors, Hyundai, Jaguar, BMW, Ford, Honda, Kia, Mercedes Benz, Mazda, Land Rover, Nissan, Mitsubishi, Volvo, Volkswagen, Toyota and Porsche. The Autoliv project manager, Hakan Pettersson expressed the excitement at being chosen as partner by NHTSA and ACTS by stating that Autoliv is looking forward to applying technology used in demonstration vehicles in real-world testing and is confident that any challenges can be overcome with advanced technology. It is estimated that the second phase of the project will be completed in two years.

To estimate the blood alcohol content in the impaired driver’s breath, Autoliv will use infrared spectroscopy as the primary sensing technology to ensure system reliability and accuracy at a low cost and low maintenance.

The program manager of DADSS, Susan A Ferguson stated that an estimated one-third of traffic fatalities are due to alcohol-impaired drivers. The aim of developing an advanced alcohol level-detection technology is to prevent drivers from operating the vehicle if their blood alcohol content (BAC) is above or equal to the permitted limit of 0.08%. A projected 8000 lives can be potentially saved in the USA once the technology has been developed.

Autoliv has 80 facilities worldwide and technical centers in 11 countries. The company manufactures and develops seatbelts, airbags, safety electronics, anti-whiplash systems, steering wheels, seat components and active safety systems that include radar and night vision systems.

Source: http://www.autoliv.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Choi, Andy. (2019, February 24). Autoliv Chosen as Research Partner for Alcohol Sensor Development. AZoSensors. Retrieved on February 20, 2024 from https://www.azosensors.com/news.aspx?newsID=3697.

  • MLA

    Choi, Andy. "Autoliv Chosen as Research Partner for Alcohol Sensor Development". AZoSensors. 20 February 2024. <https://www.azosensors.com/news.aspx?newsID=3697>.

  • Chicago

    Choi, Andy. "Autoliv Chosen as Research Partner for Alcohol Sensor Development". AZoSensors. https://www.azosensors.com/news.aspx?newsID=3697. (accessed February 20, 2024).

  • Harvard

    Choi, Andy. 2019. Autoliv Chosen as Research Partner for Alcohol Sensor Development. AZoSensors, viewed 20 February 2024, https://www.azosensors.com/news.aspx?newsID=3697.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Azthena logo with the word Azthena

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.